Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-191.22%
↓ 19% below average
Average (30q)
-161.02%
Historical baseline
Range
High:1022.69%
Low:-3290.71%
Volatility
-2678.7%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -191.22% |
| Q2 2025 | 194.52% |
| Q1 2025 | -14.60% |
| Q4 2024 | 22.50% |
| Q3 2024 | -860.00% |
| Q2 2024 | 127.78% |
| Q1 2024 | -126.95% |
| Q4 2023 | 1022.69% |
| Q3 2023 | 144.91% |
| Q2 2023 | 62.41% |
| Q1 2023 | -58.07% |
| Q4 2022 | -1.13% |
| Q3 2022 | 98.49% |
| Q2 2022 | -3290.71% |
| Q1 2022 | -67.74% |
| Q4 2021 | 13.08% |
| Q3 2021 | 173.20% |
| Q2 2021 | 105.89% |
| Q1 2021 | -661.06% |
| Q4 2020 | 119.81% |
| Q3 2020 | 10.42% |
| Q2 2020 | -1893.58% |
| Q1 2020 | 231.56% |
| Q4 2019 | 102.19% |
| Q3 2019 | -7.31% |
| Q2 2019 | -207.57% |
| Q1 2019 | -50.68% |
| Q4 2018 | 0.00% |
| Q2 2018 | 27.59% |
| Q1 2018 | -18.14% |
| Q4 2017 | 0.00% |